Clinical Trials · NCT03777982

Conventional Androgen Deprivation Therapy (ADT) With or Without Abiraterone Acetate + Prednisone and Apalutamide Following a Detectable PSA After Radiation and ADT

Name: Conventional Androgen Deprivation Therapy (ADT) With or Without Abiraterone Acetate + Prednisone and Apalutamide Following a Detectable PSA After Radiation and ADT
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

TerminatedPhase 3Gonadorelin

Phase: Phase 3
Recruitment status: Terminated
Sponsor: Dana-Farber Cancer Institute
Enrollment: 12
Start date: Apr 2020
Locations: 5 sites, United States
Primary endpoint: Metastasis Free Survival

View Gonadorelin compound reference